Your browser doesn't support javascript.
loading
The PREvention Program for Alzheimer's RElated Delirium (PREPARED) cluster randomized trial: a study protocol.
Wilchesky, Machelle; Ballard, Stephanie A; Voyer, Philippe; McCusker, Jane; Lungu, Ovidiu; Champoux, Nathalie; Vu, T T Minh; Cole, Martin G; Monette, Johanne; Ciampi, Antonio; Belzile, Eric; Carmichael, Pierre-Hugues; McConnell, Ted.
Afiliación
  • Wilchesky M; Centre for Research in Aging, Donald Berman Maimonides Geriatric Centre, 5795 Ave Caldwell, Montreal, QC, H4W 1W3, Canada. machelle.wilchesky@mcgill.ca.
  • Ballard SA; Department of Family Medicine, McGill University, 5858 Côte-des-Neiges Road, Montreal, QC, H3S 1Z1, Canada. machelle.wilchesky@mcgill.ca.
  • Voyer P; Division of Geriatric Medicine, McGill University, Jewish General Hospital, 3755 Cote St. Catherine Road, Room E-0012, Montreal, QC, H3T 1E2, Canada. machelle.wilchesky@mcgill.ca.
  • McCusker J; Centre for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, 3755 Cote St. Catherine Road, Montreal, QC, H3T 1E2, Canada. machelle.wilchesky@mcgill.ca.
  • Lungu O; Centre for Research in Aging, Donald Berman Maimonides Geriatric Centre, 5795 Ave Caldwell, Montreal, QC, H4W 1W3, Canada.
  • Champoux N; Department of Family Medicine, McGill University, 5858 Côte-des-Neiges Road, Montreal, QC, H3S 1Z1, Canada.
  • Vu TTM; Faculty of Nursing Sciences, Laval University, Pavillon Ferdinand-Vandry, 1050 avenue de la Médecine, local 3645, Québec, QC, G1V 0A6, Canada.
  • Cole MG; Centre d'excellence sur le vieillissement de Québec, Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale, 1050 chemin Sainte-Foy, L2-30, Quebec City, QC, G1S 4L8, Canada.
  • Monette J; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, 1020 Pine Ave W, Montreal, QC, H3A 1A2, Canada.
  • Ciampi A; St. Mary's Research Centre, 3830 Avenue Lacombe, Hayes Pavilion, suite 4720, Montreal, QC, H3T 1M5, Canada.
  • Belzile E; Centre for Research in Aging, Donald Berman Maimonides Geriatric Centre, 5795 Ave Caldwell, Montreal, QC, H4W 1W3, Canada.
  • Carmichael PH; Functional Neuroimaging Unit, Centre de recherche de l'Institut universitaire de gériatrie de Montréal, 4565 Queen Mary Rd, Montreal, QC, H3W 1W5, Canada.
  • McConnell T; Department of Psychiatry, Université de Montréal, Pavillon Roger-Gaudry, Faculté de Medicine, C.P. 6128, succursale Centre-ville, Montreal, QC, H3C 3J7, Canada.
BMC Geriatr ; 21(1): 645, 2021 11 16.
Article en En | MEDLINE | ID: mdl-34784897
ABSTRACT

BACKGROUND:

Delirium is a significant cause of morbidity and mortality among older people admitted to both acute and long-term care facilities (LTCFs). Multicomponent interventions have been shown to reduce delirium incidence in the acute care setting (30-73%) by acting on modifiable risk factors. Little work, however, has focused on using this approach to reduce delirium incidence in LTCFs.

METHODS:

The objective is to assess the effectiveness of the multicomponent PREPARED Trial intervention in reducing the following primary

outcomes:

incidence, severity, duration, and frequency of delirium episodes in cognitively impaired residents. This 4-year, parallel-design, cluster randomized study will involve nursing staff and residents in 45-50 LTCFs in Montreal, Canada. Participating public and private LTCFs (clusters) that provide 24-h nursing care will be assigned to either the PREPARED Trial intervention or the control (usual care) arm of the study using a covariate constrained randomization procedure. Approximately 400-600 LTC residents aged 65 and older with dementia and/or cognitive impairment will be enrolled in the study and followed for 18 weeks. Residents must be at risk of delirium, delirium-free at baseline and have resided at the facility for at least 2 weeks. Residents who are unable to communicate verbally, have a history of specific psychiatric conditions, or are receiving end-of-life care will be excluded. The PREPARED Trial intervention consists of four main components a decision tree, an instruction manual, a training package, and a toolkit. Primary study outcomes will be assessed weekly. Functional autonomy and cognitive levels will be assessed at the beginning and end of follow-up, while information pertaining to modifiable delirium risk factors, medical consultations, and facility transfers will be collected retrospectively for the duration of the follow-up period. Primary outcomes will be reported at the level of intervention assignment. All researchers analyzing the data will be blinded to group allocation.

DISCUSSION:

This large-scale intervention study will contribute significantly to the development of evidence-based clinical guidelines for delirium prevention in this frail elderly population, as it will be the first to evaluate the efficacy of a multicomponent delirium prevention program translated into LTC clinical practice on a large scale. TRIAL REGISTRATION NCT03718156 , ClinicalTrials.gov .
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Delirio / Enfermedad de Alzheimer Tipo de estudio: Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Límite: Aged / Humans Idioma: En Revista: BMC Geriatr Asunto de la revista: GERIATRIA Año: 2021 Tipo del documento: Article País de afiliación: Canadá

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Delirio / Enfermedad de Alzheimer Tipo de estudio: Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Límite: Aged / Humans Idioma: En Revista: BMC Geriatr Asunto de la revista: GERIATRIA Año: 2021 Tipo del documento: Article País de afiliación: Canadá